Market Overview
The Bioresorbable Vascular Scaffold Market is entering a period of steady expansion as healthcare providers and medical device manufacturers continue to seek safer, minimally invasive solutions for coronary artery disease. The market is anticipated to grow from $429.6 million in 2024 to $889.6 million by 2034, representing a CAGR of approximately 7.6%. Unlike permanent stents,...